Novel Advances for the Future of Vision

[unex_ce_button id="content_j84u0f7nm,column_content_1362rufwb" button_text_color="#87c4c4" button_font="regular" button_font_size="16px" button_width="auto" button_alignment="left" button_text_spacing="0px" button_bg_color="#ffffff" button_padding="10px 30px" button_border_width="0px" button_border_color="transparent" button_border_radius="4px" button_text_hover_color="#87c4c4" button_text_spacing_hover="0px" button_bg_hover_color="#efefef" button_border_hover_color="transparent" button_link="" button_link_type="url" button_link_target="_self" has_container="" in_column="1"]Watch the Video[/ce_button]

Cataract surgery is the single most common procedure performed in the United States annually. Despite technological advancements in both surgical instrumentation and intraocular lens design, approximately 50% of patients are still unable to see well without glasses after surgery.

Omega Ophthalmics® has developed a new, proprietary lens that will increase the number of “glasses free” post-surgery patients to over 90% by reducing the variables during surgery, revolutionizing a market that has not seen positive, disruptive change in over sixty years. Since the global intraocular lens market has steadily grown and is currently projected to reach $4.3 billion by 2017, the Omega Gemini Refractive CapsuleTM is well-positioned to become the new standard lens for cataract surgery.